Study reveals surprising results that may impair future therapeutic approaches in TGF

[News]

Researchers at Helmholtz Zentrum München describe how breast cancer cells challenged with a small-molecule inhibitor targeting specific invasive properties switch to an alternative mode-of-action, rendering them even more aggressive. The results may impair future therapeutic approaches in the TGF-beta pathway and are published in the journal 'Oncotarget'.

More... (http://www.news-medical.net/news/20160427/Study-reveals-surprising-results-that-may-impair-future-therapeutic-approaches-in-TGF-beta-pathway.aspx)